- Daridorexant, sold
under the
brand name
Quviviq, is an
orexin antagonist medication which is used for the
treatment of insomnia.
Daridorexant is taken...
- This
includes the
rights to
market clazosentan (Piviaz) and
daridorexant (
Quviviq) in the Asia
Pacific region excluding China, plus
rights on two
other treatments...
- FDA-approved
orexin antagonists are
lemborexant (Dayvigo) and
daridorexant (
Quviviq). In 2016, the
University of
Texas Health Science Center registered a clinical...
-
Zolpidem (Ambien)
Zopiclone (Imovane)
Orexin antagonists Daridorexant (
Quviviq)
Lemborexant (Dayvigo)
Suvorexant (Belsomra)
First generation Antihistamines...
-
treatment of
sleep disorders such as insomnia.
Daridorexant (nemorexant;
Quviviq) – dual OX1 and OX2
antagonist –
approved for
insomnia in
January 2022...
-
quisultazine (INN)
quitiapine (INN)
Quixin (Vistakon Pharmaceuticals)
quizartinib (USAN, INN)
Qulipta Quofenix Qutenza Quviviq Quzyttir Qvar
Redihaler Qvar...
-
receptor (DORA)
drugs on the market:
Belsomra (Merck),
Dayvigo (Eisai) and
Quviviq (Idorsia).
Certain atypical antipsychotics,
particularly quetiapine, olanzapine...
- 105053. doi:10.1016/j.yrtph.2021.105053. PMID 34619288. S2CID 238476630. "
Quviviq (daridorexant) tablets, for oral use, [controlled
substance schedule pending]"...
-
Almorexant (ACT-078573) – dual OX1 and OX2
receptor antagonist Daridorexant (
Quviviq; ACT-541468) – dual OX1 and OX2
receptor antagonist Filorexant (MK-6096)...
